Intech Investment Management LLC Trims Stock Holdings in Humana Inc. (NYSE:HUM)

Intech Investment Management LLC reduced its stake in Humana Inc. (NYSE:HUM) by 56.9% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 61,903 shares of the insurance provider’s stock after selling 81,723 shares during the period. Intech Investment Management LLC’s holdings in Humana were worth $23,130,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. CarsonAllaria Wealth Management Ltd. raised its holdings in Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after buying an additional 39 shares during the period. Hantz Financial Services Inc. purchased a new stake in Humana during the second quarter worth about $35,000. Family Firm Inc. purchased a new stake in Humana during the second quarter worth about $37,000. Carolinas Wealth Consulting LLC increased its stake in Humana by 274.1% during the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock worth $46,000 after purchasing an additional 74 shares during the period. Finally, Riverview Trust Co acquired a new position in shares of Humana during the second quarter worth about $44,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Trading Down 1.0 %

NYSE:HUM opened at $312.00 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. The stock has a market capitalization of $37.60 billion, a price-to-earnings ratio of 19.43, a PEG ratio of 2.56 and a beta of 0.50. Humana Inc. has a 1 year low of $298.61 and a 1 year high of $530.54. The stock has a fifty day moving average price of $359.14 and a two-hundred day moving average price of $345.90.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. Humana’s revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $8.94 earnings per share. As a group, sell-side analysts anticipate that Humana Inc. will post 16 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date is Monday, September 30th. Humana’s payout ratio is currently 22.04%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Cantor Fitzgerald reissued a “neutral” rating and set a $395.00 price objective on shares of Humana in a research report on Tuesday, September 10th. Piper Sandler assumed coverage on Humana in a research report on Wednesday, June 26th. They set an “overweight” rating and a $392.00 price objective for the company. Baird R W raised Humana to a “hold” rating in a research report on Thursday, May 30th. Oppenheimer upped their price target on Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a report on Thursday, August 1st. Finally, Truist Financial upped their price target on Humana from $355.00 to $400.00 and gave the company a “hold” rating in a report on Monday, July 15th. Thirteen investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $398.70.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.